Despite randomized trials repeatedly showing the benefits of lowering LDL cholesterol with hydroxymethylglutaryl (HMG)-CoA reductase inhibitors (statins) (1-3), these medications are suboptimally used in type 2 diabetes (4 -10). Although this care gap in type 2 diabetes has been frequently described in cross-sectional studies (6 -11), it may be as informative to understand LDL control over time. In particular, there is growing recognition of care gaps in diabetes when comparing urban and academic settings with rural settings (11,12). Therefore, we examined changes over an 18-month period for adherence to guidelinerecommended LDL cholesterol targets in a rural cohort with type 2 diabetes and determined the rates and correlates of 1) losing control of LDL cholesterol in those who were initially at target and 2) achieving control of LDL cholesterol in those who were not initially at target.
RESEARCH DESIGN AND METHODS -The Diabetes OutreachVan Enhancement (DOVE) study was a controlled trial of a multifaceted intervention directed at health care providers to improve the quality of care for rural patients with type 2 diabetes in northern Alberta, Canada. The intervention consisted of an educational outreach ("academic detailing") service, whereby specialist physicians promoted aggressive cardiovascular risk reduction for diabetes to primary care physicians. The study rationale, design, and outcomes have been previously published (12-16). All subjects provided written consent, and the study was approved by the University of Alberta.All patients had universal health care coverage and fee-for-service primary care physicians, with the nearest specialists being ϳ6 h away by vehicle. Patients were eligible if they were aged Ն20 years, had type 2 diabetes, and understood English. They were excluded for shortened life expectancy or inability to consent. Data were collected from 2000 through 2001, and patients were assessed at baseline and 18 months. Clinical data were collected by in-person interviews and physical assessments, while laboratory measurements were drawn locally and analyzed in one central laboratory.Primary outcomes were defined according to LDL cholesterol levels Ͻ2.5 mmol/l, which was the target recommended during the study (12)(13)(14)17). To explore independent correlates of guideline adherence, three multivariable logistic regression analyses were built using Stata (version 8.2; StataCorp, College Station, TX). The first model represented LDL guideline adherence at baseline; the second, loss of LDL control among those well controlled at baseline; and the third, new achievement of LDL guideline adherence over 18 months among those not controlled at baseline. The educational intervention had no effect on lipid levels or lipid-lowering medications (14 -16), but we adjusted for it in all analyses. Otherwise, candidate variables had to have a univariate significance of at least P Ͻ 0.1 and a multivariate significance of P Ͻ 0.05. RESULTS -Overall, 393 patients with type 2 diabetes were enrolled, and 346 (88%) h...